ClearPoint Neuro, Inc. (CLPT) vs Relmada Therapeutics, Inc. (RLMD)
A side-by-side comparison of ClearPoint Neuro, Inc. and Relmada Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLPT
ClearPoint Neuro, Inc.
$10.72HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
RLMD
Relmada Therapeutics, Inc.
$3.33HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT
Total return — CLPT vs RLMD
growth of $100 · dividends reinvested · last 10yCLPT +88.9% (+6.6%/yr)RLMD +200.0% (+11.6%/yr)RLMD compounded faster over this window
CLPT RLMD
CLPT vs RLMD: by the numbers
- •RLMD is the larger company ($349M vs $321M market cap).
- •Both run net losses; RLMD's is the smaller (0.00% vs -81.76% net margin).
Metrics side by side
Valuation
| Metric | CLPT | RLMD |
|---|---|---|
| P/S ratio | 7.60 | N/A |
| P/B ratio | 29.83 | 1.69 |
Profitability
| Metric | CLPT | RLMD |
|---|---|---|
| Gross margin | 62.61% | 0.00% |
| Operating margin | -65.36% | 0.00% |
| Net margin | -81.76% | 0.00% |
| ROE | -320.77% | -29.98% |
| ROIC | -40.51% | -30.78% |
Growth (annualized)
| Metric | CLPT | RLMD |
|---|---|---|
| Revenue CAGR (5Y) | 23.57% | N/A |
| Total return CAGR (5Y) | -7.65% | -7.68% |
Frequently asked
- How have CLPT and RLMD total returns compared?
- Over the past 10 years, CLPT delivered 6.57% and RLMD delivered 12.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ClearPoint Neuro ROERelmada Therapeutics ROEClearPoint Neuro operating marginRelmada Therapeutics operating marginClearPoint Neuro revenue growthRelmada Therapeutics revenue growthClearPoint Neuro free cash flowRelmada Therapeutics free cash flow
ClearPoint Neuro & Relmada Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.